Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study
ConclusionsThe development of individualized dose adjustment is critical to achieve optimal voriconazole concentration, especially among allo-HSCT recipients receiving concomitant letermovir and/or methylprednisolone.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Laboratory Medicine | Men | Methylprednisolone | Stem Cell Therapy | Stem Cells | Study | Transplants